Zhijuan Liang

1.5k total citations
31 papers, 839 citations indexed

About

Zhijuan Liang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Zhijuan Liang has authored 31 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Zhijuan Liang's work include Cancer, Hypoxia, and Metabolism (10 papers), Ferroptosis and cancer prognosis (7 papers) and Immune cells in cancer (7 papers). Zhijuan Liang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Ferroptosis and cancer prognosis (7 papers) and Immune cells in cancer (7 papers). Zhijuan Liang collaborates with scholars based in China, Finland and South Korea. Zhijuan Liang's co-authors include Yuanbin Chen, Ye Liang, Haitao Niu, Liping Wang, Dan Li, Xuecheng Yang, Guofeng Ma, Yonghua Wang, Zhilei Zhang and Zhao Zhang and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

Zhijuan Liang

28 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhijuan Liang China 16 405 293 188 181 137 31 839
Xuefeng Xia China 14 363 0.9× 257 0.9× 192 1.0× 145 0.8× 57 0.4× 33 777
Praveen Radhakrishnan Germany 17 377 0.9× 325 1.1× 265 1.4× 130 0.7× 101 0.7× 39 924
Han Yang China 18 694 1.7× 269 0.9× 201 1.1× 146 0.8× 146 1.1× 43 1.1k
Magdalena Jarosz–Biej Poland 15 362 0.9× 169 0.6× 321 1.7× 267 1.5× 108 0.8× 31 974
Mostafa Manian Iran 14 579 1.4× 395 1.3× 249 1.3× 141 0.8× 81 0.6× 26 1.1k
Qiang Tong China 19 554 1.4× 219 0.7× 182 1.0× 93 0.5× 112 0.8× 63 917
Le Li China 17 559 1.4× 337 1.2× 301 1.6× 168 0.9× 98 0.7× 46 1.0k
Margherita Cortini Italy 19 512 1.3× 213 0.7× 195 1.0× 133 0.7× 73 0.5× 27 1.0k
Joshua J. Souchek United States 16 462 1.1× 245 0.8× 326 1.7× 99 0.5× 101 0.7× 22 1.0k
Beibei Ni China 15 480 1.2× 186 0.6× 133 0.7× 104 0.6× 71 0.5× 33 740

Countries citing papers authored by Zhijuan Liang

Since Specialization
Citations

This map shows the geographic impact of Zhijuan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijuan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijuan Liang more than expected).

Fields of papers citing papers by Zhijuan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhijuan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijuan Liang. The network helps show where Zhijuan Liang may publish in the future.

Co-authorship network of co-authors of Zhijuan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhijuan Liang. A scholar is included among the top collaborators of Zhijuan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhijuan Liang. Zhijuan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wenhao, Rui Li, Weiyi Huang, et al.. (2025). RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway. Theranostics. 15(10). 4446–4464.
2.
Liu, Shenghao, Zhijuan Liang, Liping Wang, et al.. (2025). The potential role of bioactive marine polysaccharides applied in the cancer diagnosis and therapy. Carbohydrate Polymers. 375. 124771–124771. 1 indexed citations
3.
Liang, Ye, Fei Xie, Zhao Zhang, et al.. (2024). Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Letters. 593. 216964–216964. 26 indexed citations
4.
Chen, Yuanbin, Wei Jiao, Yonghua Wang, et al.. (2024). Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer. Journal of Thrombosis and Haemostasis. 22(7). 1956–1972.
5.
Ma, Guofeng, Zhiqiang Li, Liping Wang, et al.. (2024). Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer. Cancer Immunology Research. 13(1). 66–83. 3 indexed citations
6.
Wang, Liping, Zhijuan Liang, Dan Li, et al.. (2023). Synthesis and application of zeolitic imidazolate frameworks-based nucleic acid delivery system in tumor diagnosis and therapy: a review. Biomedical Materials. 18(5). 52002–52002. 5 indexed citations
7.
Liang, Zhijuan, et al.. (2022). Establishment of a novel pork kidney lavage method and detection of heavy metals and antibiotics. Food Science and Technology. 42. 2 indexed citations
8.
Liang, Zhijuan, et al.. (2022). The Impact of Specific Psychological Characteristics on Decision-Making Under the Different Conditions of Risk Self-Assessment. Frontiers in Psychology. 13. 779246–779246. 2 indexed citations
9.
Wang, Jirong, Jipeng Zhang, Youzhi Zhang, et al.. (2021). TEAD4 is an Immune Regulating-Related Prognostic Biomarker for Bladder Cancer and Possesses Generalization Value in Pan-Cancer. DNA and Cell Biology. 40(6). 798–810. 10 indexed citations
10.
Yu, Yongbo, Ye Liang, Dan Li, et al.. (2021). Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment. Cell Death Discovery. 7(1). 15–15. 59 indexed citations
11.
Chen, Yuning, Yanan Zhang, Renhong Yan, et al.. (2021). ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduction and Targeted Therapy. 6(1). 315–315. 38 indexed citations
12.
Ma, Guofeng, Chun Li, Zhilei Zhang, et al.. (2021). Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies. Frontiers in Oncology. 11. 697894–697894. 30 indexed citations
13.
Wang, Liping, Ting Xu, Xuecheng Yang, et al.. (2021). Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer. Frontiers in Molecular Biosciences. 8. 687305–687305. 20 indexed citations
14.
Liu, Jing, et al.. (2020). Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer. Cancer Cell International. 20(1). 538–538. 7 indexed citations
15.
Xu, Ting, et al.. (2020). Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer. Disease Markers. 2020. 1–13. 8 indexed citations
16.
Liang, Ye, Yonghua Wang, Liping Wang, et al.. (2020). Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer. Bioactive Materials. 6(2). 433–446. 160 indexed citations
17.
Liang, Ye, Wenhua Xu, Shihai Liu, et al.. (2018). N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5. Cellular Physiology and Biochemistry. 45(5). 2054–2070. 15 indexed citations
18.
Wang, Liping, Xuecheng Yang, Dan Li, et al.. (2018). The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ. OncoTargets and Therapy. Volume 11. 7229–7243. 12 indexed citations
19.
Liang, Zhijuan, Yuanbin Chen, Liping Wang, et al.. (2018). CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis. Cell Cycle. 18(1). 34–45. 34 indexed citations
20.
Ma, Guofeng, Xuecheng Yang, Ye Liang, et al.. (2018). Precision medicine and bladder cancer heterogeneity. Bulletin du Cancer. 105(10). 925–931. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuefeng Xia Breakdown of academic impact, for papers by Praveen Radhakrishnan Breakdown of academic impact, for papers by Han Yang Breakdown of academic impact, for papers by Magdalena Jarosz–Biej Breakdown of academic impact, for papers by Mostafa Manian Breakdown of academic impact, for papers by Qiang Tong Breakdown of academic impact, for papers by Le Li Breakdown of academic impact, for papers by Margherita Cortini Breakdown of academic impact, for papers by Joshua J. Souchek Breakdown of academic impact, for papers by Beibei Ni
Rankless by CCL
2026